<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32181601</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1755-5949</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>CNS neuroscience &amp; therapeutics</Title><ISOAbbreviation>CNS Neurosci Ther</ISOAbbreviation></Journal><ArticleTitle>Stem cell therapy and FUS[1-359]-transgenic mice: A recent study highlighting a promising ALS model and a promising therapy.</ArticleTitle><Pagination><StartPage>502</StartPage><EndPage>503</EndPage><MedlinePgn>502-503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cns.13302</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ninkina</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8570-5648</Identifier><AffiliationInfo><Affiliation>Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>CNS Neurosci Ther</MedlineTA><NlmUniqueID>101473265</NlmUniqueID><ISSNLinking>1755-5930</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>CNS Neurosci Ther. 2020 May;26(5):504-517</RefSource><PMID Version="1">31867846</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064987" MajorTopicYN="N">Cell- and Tissue-Based Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32181601</ArticleId><ArticleId IdType="pmc">PMC7163729</ArticleId><ArticleId IdType="doi">10.1111/cns.13302</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al&#x2010;Chalabi A, Chi&#xf2; A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94&#x2010;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M, Bowser R. Molecular and Cellular Therapies for Motor Neuron Diseases (61&#x2010;99); 2017. London, UK: Academic Press.</Citation></Reference><Reference><Citation>Gu Y, He M, Zhou X, et al. Endogenous IL&#x2010;6 of mesenchymal stem cell improves behavioral outcome of hypoxic&#x2010;ischemic brain damage neonatal rats by supressing apoptosis in astrocyte. Sci Rep. 2016;6:18587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725911</ArticleId><ArticleId IdType="pubmed">26766745</ArticleId></ArticleIdList></Reference><Reference><Citation>de Munter JP, Shafarevich I, Liundup A, et al. Neuro&#x2010;cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice. CNS Neurosci Ther. 2020;26:504&#x2010;517. 10.1111/cns.13280</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13280</ArticleId><ArticleId IdType="pmc">PMC7163689</ArticleId><ArticleId IdType="pubmed">31867846</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova TA, Peters OM, Deykin A, et al. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. J Biol Chem. 2013;288:25266&#x2010;25274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3757190</ArticleId><ArticleId IdType="pubmed">23867462</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivello M, Hogg MC, Jirstr&#xf6;m E, et al. Vascular regression precedes motor neuron loss in the FUS (1&#x2013;359) ALS mouse model. Dis Model Mech. 2019;12(8):1&#x2010;359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6737946</ArticleId><ArticleId IdType="pubmed">31383794</ArticleId></ArticleIdList></Reference><Reference><Citation>de Munter JP, Beugels J, Munter S, et al. Standardized human bone marrow&#x2010;derived stem cells infusion improves survival and recovery in a rat model of spinal cord injury. J Neurol Sci. 2019;402:16&#x2010;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">31100652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischbach MA, Bluestone JA, Lim WA. Cell&#x2010;based therapeutics: the next pillar of medicine. Sci Transl Med. 2013;5(179):179ps7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772767</ArticleId><ArticleId IdType="pubmed">23552369</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>